Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, but its effectiveness depends partly on how you administer it. Choosing the right injection sites and rotating them weekly helps maintain steady medication absorption and prevents tissue damage. PlexusDx patients using compounded semaglutide injection benefit from clear injection protocols that support consistent therapy outcomes.

Understanding Semaglutide Injection Site Anatomy

Semaglutide is a subcutaneous injection, meaning it goes into the fatty tissue layer just beneath your skin, not into muscle or vein. This subcutaneous placement allows the medication to absorb gradually over several days, which is why weekly dosing works effectively. The three approved injection areas—belly, outer thigh, and upper arm—all contain adequate fatty tissue to support proper absorption.

Fatty tissue blood flow varies across body zones, which affects how quickly your body processes the medication. Your abdomen typically has the most consistent blood supply, making it a reliable first choice for many patients. However, rotating between all three sites prevents lipodystrophy (fat tissue damage) and maintains predictable medication delivery over time.

Best Injection Sites for Semaglutide: Abdomen, Thigh, and Arm

Your abdomen offers the largest injection area and is often recommended as the primary site. Inject at least two inches away from your belly button, choosing either the upper or lower abdominal area. Avoid injecting directly over scars, stretch marks, or areas that feel lumpy, as these indicate previous tissue damage.

The outer thigh provides another excellent option, particularly the area on the front and outer part of your leg, roughly four inches above the knee and four inches below the hip. This site works well if you prefer to inject while seated and may feel less intimidating than abdominal injections. The upper arm (back of the arm, between shoulder and elbow) is suitable if you have someone available to help, though many patients find self-injection easier in the other two locations.

Rotation Schedule and Tissue Preservation Strategies

Rotating injection sites weekly prevents lipodystrophy, a condition where fat tissue hardens, thickens, or atrophies from repeated injections in the same spot. A simple rotation pattern—abdomen week one, right thigh week two, left thigh week three, arm week four—then repeat—ensures you return to any single area only once monthly. Within each body area, move at least one inch away from your previous injection to further minimize tissue trauma.

Inspect your skin before each injection for signs of lipodystrophy such as lumps, dimpling, or hardened areas. If you notice these changes, skip that area for at least two months and allow the tissue to recover. Proper site rotation combined with correct injection technique significantly reduces patient-reported injection discomfort and supports long-term therapy adherence.

Injection Technique and Plexusdx Support for Optimal Results

Clean your injection site with an alcohol swab and allow it to air-dry completely, as injecting into wet skin can affect medication delivery. Pinch a fold of skin gently between your thumb and forefinger to stabilize the tissue, then insert the needle at a 90-degree angle in one swift motion. This quick, confident motion typically causes less discomfort than slow insertion.

Hold the needle in place for three seconds after injecting to allow medication to disperse into surrounding tissue, then withdraw slowly. PlexusDx compounded semaglutide injections come pre-filled for weekly dosing at your prescribed level, eliminating dose-calculation confusion. Patients seeking personalized guidance on injection technique, site selection based on body composition, or medication response optimization can explore PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) to identify individual peptide-pathway predispositions that may influence therapy outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No—injecting the same spot repeatedly causes lipodystrophy (hardened or atrophied fat tissue) and reduces medication absorption. Rotating between abdomen, thighs, and upper arm, moving at least one inch within each area weekly, prevents tissue damage and maintains consistent drug delivery.

What does lipodystrophy feel like, and is it permanent?

Lipodystrophy may feel like lumps, hardness, thickening, or dimpling under the skin at injection sites. Early lipodystrophy is often reversible if you stop injecting in that area for 6-8 weeks, allowing fatty tissue to recover. Severe, long-standing cases may be slower to resolve.

How much does PlexusDx compounded semaglutide cost?

PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) across all commitment tiers, with no flat per-compound pricing increases. Your dose may need to go up. Your price won't. PlexusDx serves all 50 states with no insurance required, and injections are HSA/FSA eligible.

Should I inject into muscle instead of fat?

No—semaglutide must be injected subcutaneously (into fat), never intramuscularly. Injecting into muscle alters medication absorption unpredictably and increases injection pain and tissue damage. Proper subcutaneous placement in fatty areas ensures steady, reliable medication delivery.

Can genetic testing help me personalize my semaglutide therapy?

Yes—PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways, revealing individual peptide-response predispositions that may guide therapy optimization and expected weight loss patterns.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves